The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections

被引:57
作者
Chamilos, Georgios
Macapinlac, Homer A. [1 ]
Kontoyiannis, Dimitrios P. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Nucl Med, Houston, TX 77030 USA
关键词
Aspergillus; Zygomycetes; diagnosis; haematological malignancies; invasive mould infections; FDG-PET imaging;
D O I
10.1080/13693780701639546
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
There is limited information on the utility of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) for the diagnosis and management of invasive mould infections (IMIs). We retrospectively evaluated patients with IMIs who underwent FDG-PET in our institution (n = 13; December 1999 to April 2004), and reviewed the available literature (n = 9). In 16 non-neutropenic patients with available FDG-PET imaging studies (11 from our institution), FDG-PET revealed an occult IMI site (n = 3; 2 unidentified CNS involvement) and was helpful in guiding the duration of treatment (n = 8). Prospective evaluation of the role of FDG-PET in the work-up and management of IMIs is needed.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 20 条
[1]   Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus [J].
Ascioglu, S ;
Rex, JH ;
de Pauw, B ;
Bennett, JE ;
Bille, J ;
Crokaert, F ;
Denning, DW ;
Donnelly, JP ;
Edwards, JE ;
Erjavec, Z ;
Fiere, D ;
Lortholary, O ;
Maertens, J ;
Meis, JF ;
Patterson, TF ;
Ritter, J ;
Selleslag, D ;
Shah, PM ;
Stevens, DA ;
Walsh, TJ .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) :7-14
[2]   Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis [J].
Balloy, V ;
Huerre, M ;
Latgé, JP ;
Chignard, M .
INFECTION AND IMMUNITY, 2005, 73 (01) :494-503
[3]  
Bleeker-Rovers CP, 2005, J NUCL MED, V46, P2014
[4]   Diagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography [J].
Bleeker-Rovers, CP ;
Warris, A ;
Drenth, JPH ;
Corstens, FHM ;
Oyen, WJG ;
Kullberg, BJ .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (06) :493-495
[5]  
Chamilos G, 2006, HAEMATOL-HEMATOL J, V91, P986
[6]   Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases [J].
De Winter, F ;
Vogelaers, D ;
Gemmel, F ;
Dierckx, RA .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2002, 21 (04) :247-257
[7]  
Dumarey N, 2006, J NUCL MED, V47, P625
[8]  
EURBANK WB, 2001, J CLIN ONCOL, V19, P3516
[9]   Therapy monitoring in aspergillosis using F-18FDG positron emission tomography [J].
Franzius, C ;
Biermann, M ;
Hülskamp, G ;
Frosch, M ;
Roth, J ;
Sciuk, J ;
Schober, O .
CLINICAL NUCLEAR MEDICINE, 2001, 26 (03) :232-233
[10]   Evaluation of dissemination studies with FDG whole-body positron emission tomography in patients with suspected metastatic tumours of brain and spine [J].
Go, KG ;
Pruim, J ;
Que, TH ;
Vaalburg, W ;
Haaxma-Reiche, H .
ACTA NEUROCHIRURGICA, 2000, 142 (06) :627-631